Edition:
India

Chromadex Corp (CDXC.OQ)

CDXC.OQ on NASDAQ Stock Exchange Capital Market

3.46USD
1:30am IST
Change (% chg)

$-0.10 (-2.81%)
Prev Close
$3.56
Open
$3.60
Day's High
$3.62
Day's Low
$3.46
Volume
24,439
Avg. Vol
70,737
52-wk High
$7.24
52-wk Low
$2.86

Summary

Name Age Since Current Position

Robert Fried

58 2018 President, Chief Strategy Officer, Chief Operating Officer, Director

Frank Jaksch

48 2013 Chief Executive Officer, Director

Kevin Farr

60 2017 Chief Financial Officer, Secretary, Principal Accounting Officer and Principal Financial Officer

Troy Rhonemus

44 2018 Executive Vice President

Lisa Bratkovich

2018 Chief Marketing Officer

Mark Friedman

2018 General Counsel and Corporate Secretary

Andrew Johnson

2017 Director of Investor Relations, IR Contact Officer

Tony Lau

2017 Director

Steven Rubin

56 2017 Director

Wendy Yu

2017 Director

Jeffrey Baxter

55 2015 Independent Director

Stephen Block

72 2011 Independent Director

Kurt Gustafson

49 2017 Independent Director

Biographies

Name Description

Robert Fried

Mr. Robert N. Fried serves as President, Chief Executive Officer, Chief Operating Officer, Chief Strategy Officer, Director of the Company, effective June 22, 2018. He has served as a director of the Company since July 2015 and served as a member of the Nominating and Corporate Governance Committee from July 2015 to March 2017. In March 2017, Mr. Fried was appointed as President and Chief Strategy Officer of the Company. Mr. Fried served as Chairman of the Board of Directors of IDI, Inc. (formerly Tiger Media, Inc.), an information solutions provider focused on the data fusion market and formerly a Chinese advertising company prior to its merger with the parent company of Interactive Data, LLC, from 2011 until June 2015. From 2007 through 2009, he was the president, Chief Executive Officer and a director of Ideation Acquisition Corporation, a special purpose acquisition company. Mr. Fried is the founder and Chief Executive Officer of Feeln, a subscription streaming video service, which was acquired by Hallmark Cards Inc. in 2012. Since then, Mr. Fried manages digital businesses for Hallmark including Feeln, Hallmark e-cards, and Hallmark Print on Demand. Mr. Fried is also an Academy Award winning motion picture producer whose credits include Rudy, Collateral, Boondock Saints, So I Married an Axe Murderer, Godzilla, and numerous others. From December 1994 until June 1996, he was President and Chief Executive Officer of Savoy Pictures, a unit of Savoy Pictures Entertainment, Inc., which was sold in 1996 to Silver King Communications, which is now a part of InterActive Corp. Mr. Fried has also held several executive positions including Executive Vice President in charge of Production for Columbia Pictures, Director of Film Finance and Special Projects for Columbia Pictures, and Director of Business Development at Twentieth Century Fox. Mr. Fried holds an M.S. from Cornell University and an M.B.A. from the Columbia University Graduate School of Business.

Frank Jaksch

Mr. Frank L. Jaksch is no longer Chief Executive Officer, Director of ChromaDex Corporation., effective June 22, 2018. He is a co-founder of the Company and has served as a member of Board since February 2000. Mr. Jaksch served as Chairman of the Board from May 2010 to October 2011 and was its Co-Chairman from February 2000 to May 2010. Mr. Jaksch currently serves as our Chief Executive Officer. Mr. Jaksch oversees research, strategy and operations for the Company with a focus on scientific and novel products for pharmaceutical and nutraceutical markets. From 1993 to 1999, Mr. Jaksch served as International Subsidiaries Manager of Phenomenex, a life science supply company where he managed the international subsidiary and international business development divisions. Mr. Jaksch earned a B.S. in Chemistry and Biology from Valparaiso University.

Kevin Farr

Mr. Kevin M. Farr CPA., serves as a Chief Financial Officer, Secretary, Principal Accounting Officer and Principal Financial Officer of the Company. Farr is joining ChromaDex from Mattel, Inc., where he was Executive Vice President and CFO since 2000. Farr brings extensive global experience in building iconic consumer brands, including American Girl, Barbie, Fisher-Price, Hot Wheels and Thomas & Friends. Farr has extensive global S&P 500 public company experience in corporate finance, treasury, tax, investor relations, strategic planning, corporate development, mergers and acquisitions, information technology, operational efficiency and transformation programs, and capital market transactions. Mr. Farr serves on the board of directors and is Chairman of the Audit Committee of Polaris, Inc., as well as on the Corporate Advisory Board of the Marshall School of Business at the University of Southern California. Kevin received his master's degree at Northwestern University and is a Certified Public Accountant. Prior to joining Mattel, he worked at PricewaterhouseCoopers for 10 years.

Troy Rhonemus

Mr. Troy Rhonemus serves as a Executive Vice President of the Company. He was Chief Operating Officer of the ChromaDex Corp. since March 2014. Mr. Rhonemus is Director of New Technology and Supply Chain from January 2013 to February 2014. Mr. Rhonemus is responsible for overseeing all of Company’s operations including all aspects of sales, marketing, supply chain management, distribution, and new technology development. Mr. Rhonemus also consults with customers to improve the supply chain management of raw materials to meet government regulations, which includes developing supply chain strategies, auditing manufacturers and developing an understanding of how to manage supplies from countries outside the Unites States. Mr. Rhonemus has extensive experience in managing operations and supply chain, business strategies, and the roll-out of new processes, technologies and products. From 2006 to 2012, Mr. Rhonemus held several positions at Cargill, Inc. As Truvia® Business Process Manager, he served as the product line lead for managing the operations and supply chain of the Truvia® enterprise from leaf to consumer products. As Technology Manger, Mr. Rhonemus served as technical lead for process and product development for Truvia® consumer products and ingredient business. From 2004 to 2006, Mr. Rhonemus served as Principal Research Scientist at E&J Gallo Winery, where he developed experimental designs to ensure that all project work was statistically valid in the lab, pilot and production wineries. From 1998 to 2004, Mr. Rhonemus served as Senior Research Scientist and as Process Technology Manager at Cargill, Inc. In these positions, Mr. Rhonemus solved technical problems and implemented new technologies into production. He identified potential tolling facilities, coordinated tolling efforts, directly supervised and developed new processes and solved technical issues in existing business units in Cargill. Mr. Rhonemus has earned a M.A. in Chemistry and a B.S. in Chemistry from Ball State University.

Lisa Bratkovich

Ms. Lisa Bratkovich is Chief Marketing Officer of the company. She is joining ChromaDex from Direct Upside Group, a direct-to-consumer marketing and customer experience transformation consulting firm, where she has served as CEO and Principal since 2016. Prior to starting her own firm, Bratkovich spent 13 years at Guthy|Renker, where she served as Senior Vice President of Marketing. Bratkovich has spent her career growing and refining the branding, marketing and customer experience of numerous direct-to-consumer products, most notably helping catapult brands at Guthy|Renker, such as Proactiv ® and Meaningful Beauty ® , into renowned health and beauty brands, each with hundreds of millions of dollars in annual revenue. Bratkovich is a graduate of the University of California - Los Angeles and is a board member of Girls in Tech, Los Angeles, which empowers women with education, resources and tools to help advance their careers in technology. She is also a board member of Organization of Women Executives, a Southern California peer network of high-achieving, executive-level women.

Mark Friedman

Mr. Mark Friedman is General Counsel and Corporate Secretary of the company. He is joining ChromaDex from Herbalife Nutrition – a global nutrition company that operates in more than 90 countries worldwide – where he served as Executive Vice President and General Counsel and Counsel to the Executive Chairman since 2013. Prior to that he acted as General Counsel, Senior Vice President, Business Development at pinkberry, Senior Vice President and General Counsel at American Golf Corporation and Senior Counsel and Associate Corporate Secretary for Atlantic Richfield Company and BP.

Andrew Johnson

Tony Lau

Mr. Tony Lau serves as a Director of the company. He is currently serves as a Director of Horizons Ventures Limited, an affiliate of Champion River, and as of August 18, 2017.

Steven Rubin

Mr. Steven D. Rubin, Esq.,J.D., serves as a Director of the Company. He has served as OPKO Health, Inc.’s (NASDAQ: OPK) Executive Vice President – Administration since May 2007 and as a director of since February 2007. Mr. Rubin is a member of The Frost Group, LLC, a private investment firm. He has extensive experience as a practicing lawyer, and as general counsel and board member to multiple public companies.

Wendy Yu

Ms. Wendy Yu serves as a Director of the company. She is currently serves as Chief Digital Officer of Horizons Digital Group, an affiliate of Pioneer, and as of August 18, 2017.

Jeffrey Baxter

Mr. Jeffrey Baxter serves as an Independent Director of ChromaDex Corporation. He has been the Chief Executive Officer and a director of VBI Vaccines Inc. (NASDAQ: VBIV) since September 2009. Previously, he was a managing partner for the venture capital firm, The Column Group. Until July of 2006, Mr. Baxter was SVP, R&D Finance and Operations, of GlaxoSmithKline (GSK). In his 19 years of pharma experience, he has held line management roles in commercial, manufacturing and IT and the office of the CEO. His most recent position in R&D included responsibility for finance, pipeline resource planning and allocation, business development deal structuring and SROne (GSK’s in-house $125 million venture capital fund). He also chaired GSK’s R&D Operating Board. Prior to GSK, he worked at Unilever and British American Tobacco. Mr. Baxter was educated at Thames Valley University and is a Fellow of the Chartered Institute of Management Accountants (FCMA).

Stephen Block

Mr. Stephen A. Block serves as an Independent Director of ChromaDex Corporation. From May 2010 to October 2011, Mr. Block has been a director of the Company since October 2007 and Chair of the Compensation Committee and a member of the Audit Committee since October 2007. From May 2010 to October 2011, Mr. Block served as Lead Independent Director to the Board. Mr. Block is also a director and chair of the nominating and corporate governance committee and a member of the audit committee of Senomyx, Inc. (NASDAQ:SNMX). He has served on the board of directors of Senomyx, Inc. since 2005. Since September 2013, he has served as a director of GetThis, Corp., Mr. Block currently serves as an industry consultant and as a Managing Director of Venture Farm LLC, an early stage venture capital firm, and as a Venture Partner of K5 Venture Partners, LLC, an Orange County early stage venture firm. He is also a Managing Director of K5 Venture Partner, LLC’s affiliated accelerator K5 Launch and a member of the executive committee of the Orange County network of Tech Coast Angels, a leading investing group. Mr. Block received his B.A. cum laude in Russian Studies from Yale University and his law degree from Harvard Law School.

Kurt Gustafson

Mr. Kurt A. Gustafson serves as Lead Independent Director of the Company, effectiev June 22 2018. He has more than 25 years of diverse experience in corporate finance. He currently serves as chief financial officer, principal accounting officer and executive vice president of Spectrum Pharmaceuticals, Inc. He previously served as the chief financial officer of Halozyme Therapeutics, Inc. (2009 – 2013). From 1991 to 2009 he worked at Amgen, holding various financial roles as vice president finance, chief financial officer of Amgen International and treasurer. Prior to joining Amgen, he worked in public accounting as staff auditor at Laventhol & Horwath in Chicago. He has been an independent director of Xencor, Inc. since 2014. Mr. Gustafson holds a B.A. degree in Accounting from North Park University in Chicago and an M.B.A from University of California, Los Angeles.